Skip to main content
SpringerLink
Log in
Book cover

Office-Based Infertility Practice pp 195–202Cite as

Complications of Ovulation Induction

  • Chapter

  • 102 Accesses

Abstract

Over 2 million women age 15–44 years are estimated to have taken fertility drugs in the United States. This number will continue to increase as more women seek treatment for infertility, and many undergo treatment with ovulation induction agents. Thus it is important to be aware of the possible complications associated with superovulation so we can adequately counsel, diagnose, and treat our patients appropriately. We discuss here several iatrogenic complications associated with the use of ovulation induction agents, including ovarian hyperstimulation syndrome, multifetal gestations, preterm delivery, heterotopic/ectopic pregnancy, spontaneous abortion, and the theoretic risk of a possible increase in the incidence of ovarian cancer.

This is a preview of subscription content, log in via an institution.

Chapter
USD   29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD   39.99
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD   54.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Learn about institutional subscriptions

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

Suggested Reading

  • Antsaklis AJ, Drakakis P, Vlazakis GP, et al. Reduction of multifetal pregnancies to twins does not increase obstetric or perinatal risks. Hum Reprod 1999; 14: 1338–1340.

    Article  PubMed  CAS  Google Scholar 

  • ASRM Practice Committee Report. Guidelines on Number of Embryos Transferred, November 1999.

    Google Scholar 

  • ASRM Practice Committee Report. Multiple Pregnancy Associated with Infertility Therapy, November 2000.

    Google Scholar 

  • Bohrer M, Kemmann E. Risk factors for spontaneous abortion in menotropin-treated women. Fertil Steril 1987;48:571–575.

    PubMed  CAS  Google Scholar 

  • Bristow RE, Karlan BY. Ovulation induction, infertility, and ovarian cancer risk. Fertil Steril 1996;66:499–507.

    PubMed  CAS  Google Scholar 

  • Bristow RE, Karlan BY. The risk of ovarian cancer after treatment for infertility. Curr Opin Obstet Gynecol 1996;8:32–37.

    PubMed  CAS  Google Scholar 

  • Fisch JD, Milki AA, Behr B. Sibling embryo blastocyst development correlates with the in vitro fertilization day 3 embryo transfer pregnancy rate in patients under age 40. Fertil Steril 1999;71:750–752.

    Article  PubMed  CAS  Google Scholar 

  • Fluker MR, Copeland JE, Yuzpe AA. An ounce of prevention: outpatient management of the ovarian hyper-stimulation syndrome. Fertil Steril 2000;73:821–824.

    Article  PubMed  CAS  Google Scholar 

  • Gross TP, Schlesselman JJ. The estimated effect of oral contraceptive use on the cumulative risk of epithelial ovarian cancer. Obstet Gynecol vol. 83 p. 619–626, 1996.

    Google Scholar 

  • Haning RV Jr, Canick JA, Goldsmith LT, et al. The effect of ovulation induction on the concentration of maternal serum relaxin in twin pregnancies. Am J Obstet Gynecol 1996;174:227–232.

    Article  PubMed  CAS  Google Scholar 

  • Hartge P, Schiffman MH, Hoover R, et al. A case control study of epithelial ovarian cancer. Am J Obstet Gynecol 1989;161:10–16.

    PubMed  CAS  Google Scholar 

  • Helzlsouer KJ, Alberg AJ, Gordon GB, et al. Serum gonadotropins and steroid hormones and the development of ovarian cancer. JAMA 1995;274:1926–1930.

    Article  PubMed  CAS  Google Scholar 

  • Hock DL, Scifer DB. Ovarian hyperStimulation syndrome. Infertil Reprod Med Clin North Am 2000; 11:399.

    Google Scholar 

  • Houmard BS, Scifer DB. Infertility treatment and informed consent: current practices of reproductive endocrinologists. Obstet Gynecol 1999;93:252–257.

    Article  PubMed  CAS  Google Scholar 

  • Krasnow JS, Berga SL, Guzick DS, Zeleznik AJ, Yeo K-T. Vascular permeability factor and vascular endothelial growth factor in ovarian hyperstimulation syndrome: a preliminary report. Fertil Steril 1996;65: 552–555.

    PubMed  CAS  Google Scholar 

  • Lyons CA, Wheeler CA, Frishman GN, et al. Early and late presentation of the ovarian hyperstimulation syndrome: two distinct entities with different risk factors. Hum Reprod 1994;9:792–799.

    PubMed  CAS  Google Scholar 

  • Mathur RS, Akande AV, Keay SD, et al. Distinction between early and late ovarian hyperstimulation syndrome. Fertil Steril 2000;73:901–907.

    Article  PubMed  CAS  Google Scholar 

  • McElhinney B, McClure N. Ovarian hyperstimulation syndrome. Baillieres Best Pract Res Clin Obstet Gynaecol 2000; 14:103–122.

    Article  PubMed  CAS  Google Scholar 

  • Ron EL, Lunenfeld B, Menczer J, et al. Cancer incidence in a cohort of infertile women. Am J Epidemiol 1987; 125:780–790.

    PubMed  CAS  Google Scholar 

  • Rossing MA, Daling JR, Weiss NS, et al. Ovarian tumors in a cohort of infertile women. N Engl J Med 1994; 331:771–776.

    Article  PubMed  CAS  Google Scholar 

  • Schenker, et al. Complications of assisted reproductive techniques. Fertil Steril 1994;61:411–422.

    PubMed  CAS  Google Scholar 

  • Schildkraut JM, Schwingt PJ, Bastos E, Evanoff A, Hughes C. Epithelial ovarian cancer risk among women with polycystic ovary syndrome. Obstet Gynecol 1996; 88:554–559.

    Article  PubMed  CAS  Google Scholar 

  • Sherwood OD. Relaxin. In: Knobil E, Neill (eds) The Physiology of Reproduction. New York: Raven, 1988: 585–673.

    Google Scholar 

  • Shu XO, Brinton LA, et al. Population-based case-control study of ovarian cancer in Shanghai. Cancer Res 1989;49:3670–3674.

    PubMed  CAS  Google Scholar 

  • Spirtas R, Kaufman SC, Alexander NJ. Fertility drugs and ovarian cancer: red alert or red herring? Fertil Steril 1993;59:291–293.

    PubMed  CAS  Google Scholar 

  • Strandell A, Thorburn J, Hamberger L. Risk factors for ectopic pregnancy in assisted reproduction. Fertil Steril 1999;71:282–286.

    Article  PubMed  CAS  Google Scholar 

  • Tal J, Haddad S, Gordon N, Timor-Tritsch I. Heterotopic pregnancy after ovulation induction and assisted reproductive technologies: a literature review from 1971 to 1993. Fertil Steril 1996;66:1–12.

    PubMed  CAS  Google Scholar 

  • Venn A, Watson L, Lumley J, et al. Breast and ovarian cancer incidence after infertility and in vitro fertilization. Lancet 1995;346:995–1000.

    Article  PubMed  CAS  Google Scholar 

  • Weiss G, Goldsmith LT, Sachdev R, et al. Elevated firsttrimester serum relaxin concentrations in pregnant women following ovarian stimulation predict prematurity and preterm delivery. Obstet Gynecol 1993;82: 821–828.

    PubMed  CAS  Google Scholar 

  • Whelan J III, Vlahos N. The ovarian hyperstimulation syndrome. Fertil Steril 2000;73:883.

    Article  PubMed  Google Scholar 

  • Whittemore AS, Harris R, Itnyre J, et al. Characteristics relating to ovarian cancer risk: collaborative analysis of 12 US case-control studies. Part II. Am J Epidemiol 1992;136:1184–1203.

    PubMed  CAS  Google Scholar 

Download references

Authors
  1. Janee A. Fonslick
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. David B. Seifer
    View author publications

    You can also search for this author in PubMed Google Scholar

Editor information

Editors and Affiliations

  1. Division of Reproductive Endocrinology and Infertility, UMDNJ-Robert Wood Johnson Medical School, 303 George Street, 08901, New Brunswick, New Jersey, USA

    David B. Seifer M.D. (Director, Professor of Obstetrics, Gynecology and Reproductive Sciences) (Director, Professor of Obstetrics, Gynecology and Reproductive Sciences)

  2. UMDNJ-Robert Wood Johnson Medical School, 303 George Street, 08901, New Brunswick, New Jersey, USA

    David B. Seifer M.D. (Director, Professor of Obstetrics, Gynecology and Reproductive Sciences) (Director, Professor of Obstetrics, Gynecology and Reproductive Sciences)

  3. The Reproductive Center, 44514, Youngstown, Ohio, USA

    Robert L. Collins M.D. (Medical Director, Reproductive Endocrinologist, Associate Professor) (Medical Director, Reproductive Endocrinologist, Associate Professor)

  4. Department of Obstetrics and Gynecology, Northeast Ohio University College of Medicine, 44272, Rootstown, Ohio, USA

    Robert L. Collins M.D. (Medical Director, Reproductive Endocrinologist, Associate Professor) (Medical Director, Reproductive Endocrinologist, Associate Professor)

Rights and permissions

Reprints and permissions

Copyright information

© 2002 Springer-Verlag New York, Inc.

About this chapter

Cite this chapter

Fonslick, J.A., Seifer, D.B. (2002). Complications of Ovulation Induction. In: Seifer, D.B., Collins, R.L. (eds) Office-Based Infertility Practice. Springer, Berlin, Heidelberg. https://doi.org/10.1007/978-3-642-87690-5_19

Download citation

  • DOI: https://doi.org/10.1007/978-3-642-87690-5_19

  • Publisher Name: Springer, Berlin, Heidelberg

  • Print ISBN: 978-3-642-87692-9

  • Online ISBN: 978-3-642-87690-5

  • eBook Packages: Springer Book Archive

Publish with us

Policies and ethics

Search

Navigation